October 23, 2024 05:41 PM EDT
Pharma
FDA+

Adults 50 and up should get pneu­mo­coc­cal vac­cine, CDC ad­vi­sors say, in boost to Pfiz­er and Mer­ck

Max Bayer

Pharma Reporter

More peo­ple are now ad­vised to get a pneu­mo­coc­cal vac­cine if they haven’t al­ready, as CDC ad­vi­sors rec­om­mend­ed the shots for adults 50 and old­er …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times